Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 29

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 29
---
 Stock Split Proposal is approved and the Board believes
that effecting the Reverse Stock Split is in our best interest and the best interest of our stockholders, the Board may effect the Reverse
Stock Split, regardless of whether our stock is at risk of delisting from Nasdaq Capital Market, for purposes of enhancing the liquidity
of the Common Stock and to facilitate capital raising.

To increase the number of additional shares issuable under the Company’s charter.A Reverse Stock Split will reduce the nominal number of shares of Common Stock outstanding and
the number of shares of Common Stock issuable on exercise of outstanding warrants, while leaving the number of shares issuable under our
charter unchanged. A Reverse Stock Split will therefor effectively increase the number of shares of the Common Stock that we are able
to issue. This effective increase will facilitate future capital fundraising on our part. Some investors may find the Common Stock more
attractive if the Reverse Stock Split is effected with additional assurance that we are unlikely to be limited in our ability to access
needed capital by the number of shares of our Common Sock authorized for issuance. However, other investors may find the Common Stock
a less attractive investment with the knowledge that additional dilution of the Common Stock is possible.

Potential Anti-takeover Effects of the Reverse Stock Split

SEC Release No. 34-15230 requires disclosure and discussion of the effects of any action, including the proposals discussed herein, that may
be used as an anti-takeover mechanism. The relative increase in the number of shares of our Common Stock available for issuance vis-à-vis
the outstanding shares of our Common Stock, could, under certain circumstances, have an anti-takeover effect, although this is not the
purpose or intent of the Board. It could potentially deter takeovers, including takeovers that the Board has determined are not in the
best interest of our stockholders, in that additional shares could be issued (within the limits imposed by applicable law) in one or
more transactions that could make a change in control or takeover more difficult. For example, we could issue additional shares so as
to dilute the stock ownership or voting rights of persons seeking to obtain control without our agreement. Similarly, the issuance of
additional shares to certain persons allied with our management could have the effect of making it more difficult to remove our current
management by diluting the stock ownership or voting rights of persons seeking to cause such removal. The increase in the number of shares
of authorized Common Stock therefore may have the effect